Towards disease modification in osteoarthritis

被引：2
|
作者：
Dell'Accio, Francesco [1 ]
De Bari, Cosimo [2 ]
机构：
[1] Queen Mary Univ London, William Harvey Res Inst, London, England
[2] Univ Aberdeen, Ctr Arthrit & Musculoskeletal Hlth, Aberdeen, Scotland
来源：
OSTEOARTHRITIS AND CARTILAGE | 2023年 / 31卷 / 09期
关键词：
LIPID-METABOLISM; INHIBITION; ANGPTL3;
D O I：
10.1016/j.joca.2023.05.002
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
In December 2022, Gerwin et al published in Nature Medicine that the C-terminal portion of angiopoietin-like 3, called LNA043, has chondroprotective and cartilage-regenerative properties. Molecular data from an experimental medicine phase I study suggested potential efficacy in humans. Here, we respond to and complement a commentary from Vincent and Conaghan and discuss unresolved issues and the potential of this molecule as a disease-modifying osteoarthritis drug. (c) 2023 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.
引用
收藏
页码：1154 / 1155
页数：2
相关论文
共 50 条
  • [41] Disease modification by RS-130830, a collagenase-3 selective inhibitor in experimental osteoarthritis (OA).
    Lollini, L
    Haller, J
    Eugui, EM
    Womble, S
    Martin, R
    Campbell, J
    Hendricks, T
    Broka, C
    Moskowitz, R
    VanWart, H
    Caulfield, JP
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 341 - 341
  • [42] R399E, A Mutated Form of Growth and Differentiation Factor 5, for Disease Modification of Osteoarthritis
    Gigout, Anne
    Werkmann, Daniela
    Menges, Stephanie
    Brenneis, Christian
    Henson, Frances
    Cowan, Kyra J.
    Musil, Djordje
    Thudium, Christian S.
    Guehring, Hans
    Michaelis, Martin
    Kleinschmidt-Doerr, Kerstin
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 (03) : 375 - 386
  • [43] Confirmation of glucosamine sulfate as an osteoarthritis disease modification agent: a long-term, randomized, placebo-controlled, independent trial on knee osteoarthritis progression
    Pavelka, K.
    Gatterova, J.
    Olejarova, M.
    Machacek, S.
    Gonzalez, C.
    Giacovelli, G.
    Rovati, L. C.
    RHEUMATOLOGY, 2001, 40 : 107 - 107
  • [44] OSTEOARTHRITIS: ANINFLAMMATORY DISEASE?
    Eymard, F.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S201 - S202
  • [45] CLASSIFICATION OF DISEASE - OSTEOARTHRITIS
    ALTMAN, RD
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 1991, 20 (06) : 40 - 47
  • [46] OSTEOARTHRITIS IS AN INFLAMMATORY DISEASE
    Berenbaum, F., Sr.
    OSTEOARTHRITIS AND CARTILAGE, 2012, 20 : S5 - S5
  • [47] Targeting osteoarthritis: The disease
    Fox, S
    VETERINARY MEDICINE, 2005, : 1 - 5
  • [48] Is Osteoarthritis a Vascular Disease?
    Olansen, Jon
    Dyke, Jonathan P.
    Aaron, Roy K.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (03):
  • [49] Osteoarthritis is a serious disease
    Hawker, G. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (05) : 3 - 6
  • [50] Osteoarthritis — an untreatable disease?
    Heike A. Wieland
    Martin Michaelis
    Bernhard J. Kirschbaum
    Karl A. Rudolphi
    Nature Reviews Drug Discovery, 2005, 4 : 331 - 344
12345